tiprankstipranks
GH Research (GHRS)
NASDAQ:GHRS
US Market
GHRS
GH Research
RESEARCH TOOLSreports

GH Research (GHRS) Stock News & Sentiment

322 Followers
GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy
Premium
Company Announcements
GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy
17d ago
6K
GHRS
GH Research to Join Stifel 2026 Virtual CNS Forum Fireside Chat
Premium
Company Announcements
GH Research to Join Stifel 2026 Virtual CNS Forum Fireside Chat
27d ago
6K
GHRS
GH Research: Advancing GH001 Toward 2026 Pivotal Phase 3 in Treatment-Resistant Depression With Favorable Risk-Reward and $70 Target
Premium
Ratings
GH Research: Advancing GH001 Toward 2026 Pivotal Phase 3 in Treatment-Resistant Depression With Favorable Risk-Reward and $70 Target
1M ago
GHRS
GH Research: Advancing Phase 3 TRD Program Post‑Hold with Strong Cash Runway Supports Buy Rating
Premium
Ratings
GH Research: Advancing Phase 3 TRD Program Post‑Hold with Strong Cash Runway Supports Buy Rating
1M ago
GHRS
GH Research: Phase 3 Readiness, Expanding Indications, and Valuation Upside Reinforce Buy Rating
Premium
Ratings
GH Research: Phase 3 Readiness, Expanding Indications, and Valuation Upside Reinforce Buy Rating
1M ago
GHRS
GH Research Posts 2025 Results as TRD Drug GH001 Clears Key Phase 2b Milestone
Premium
Company Announcements
GH Research Posts 2025 Results as TRD Drug GH001 Clears Key Phase 2b Milestone
1M ago
6K
GHRS
GH Research to Present at RBC Capital Markets Psychedelics Symposium
Premium
Company Announcements
GH Research to Present at RBC Capital Markets Psychedelics Symposium
3M ago
6K
GHRS
More GHRS News >

GHRS News on the Web

Lynx1 Capital Management LP Increases Stake in Korro Bio Inc
GuruFocus News
Neutral
Psychedelic: Compass Pathways, NRx Pharma report earnings results
TipRanks News
Bullish
GH Research Publishes Phase 2b GH001 TRD Data and Highlights Severity-Independent Efficacy
TipRanks News
Bullish
GH Research announces publication of Phase 2b results for mebufotenin
TipRanks News
Bullish
GH Research to Join Stifel 2026 Virtual CNS Forum Fireside Chat
TipRanks News
Neutral
GH Research: Advancing GH001 Toward 2026 Pivotal Phase 3 in Treatment-Resistant Depression With Favorable Risk-Reward and $70 Target
TipRanks News
Bullish
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
TipRanks News
Bullish
GH Research price target raised to $34 from $29 at Guggenheim
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
GHRS
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GHRS’s Media Buzz Sentiment?
1 articles about GHRS were published this week. In an average week, 1.25 articles are published.
    What is GHRS’s weekly average amount of articles?
    In an average week, 1.25 articles about GHRS are published.
      What is GHRS’s News Sentiment?
      50% of articles about GHRS were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week